Mylan-UpJohn merger as Viatris provides opportunity to focus on biosimilar launch and uptake EP News Bureau Mar 16, 2021 Following the news that the European Medicines Agency (EMA) has approved Kixelle, Biocon/Mylan’s biosimilar of Novo Nordisk’s…
